[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review

March 2021 | 68 pages | ID: ID99C583332CEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and for cancer. The company’s portfolio encompasses sequencing kits and reagents; sequencing tools and systems; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina serves pharmaceutical companies, academic institutions, genomic research centers, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

Illumina Inc Key Recent Developments

Feb 23,2021: US Court grants MGI's motion to amend in suit against Illumina
Feb 11,2021: Illumina reports financial results for fourth quarter and fiscal year 2020
Feb 08,2021: Illumina acelerator invests in nine genomics startups for second global cycle
Jan 31,2021: Illumina and Sequoia Capital China partner to launch genomics incubator in China
Jan 21,2021: MGI concurs with UK court's ruling to invalidate Illumina's patent

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Illumina Inc - Key Facts
Illumina Inc - Key Employees
Illumina Inc - Key Employee Biographies
Illumina Inc - Major Products and Services
Illumina Inc - History
Illumina Inc - Company Statement
Illumina Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Illumina Inc - Business Description
Product Category: Consumables
Overview
Performance
Product Category: Instruments
Overview
Performance
Product Category: Service and Other Revenue
Overview
Performance
Product Category: Microarray Products
Performance
Product Category: Sequencing Platforms
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific (Excluding Greater China)
Performance
Geographical Segment: Europe, Middle East, and Africa
Performance
Geographical Segment: Greater China
Performance
R&D Overview
Illumina Inc - Corporate Strategy
Illumina Inc - SWOT Analysis
SWOT Analysis - Overview
Illumina Inc - Strengths
Illumina Inc - Weaknesses
Illumina Inc - Opportunities
Illumina Inc - Threats
Illumina Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Illumina Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Illumina Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Illumina Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 23, 2021: US Court grants MGI's motion to amend in suit against Illumina
Feb 11, 2021: Illumina reports financial results for fourth quarter and fiscal year 2020
Feb 08, 2021: Illumina acelerator invests in nine genomics startups for second global cycle
Jan 31, 2021: Illumina and Sequoia Capital China partner to launch genomics incubator in China
Jan 21, 2021: MGI concurs with UK court's ruling to invalidate Illumina's patent
Jan 20, 2021: Illumina wins patent infringement suit against BGI in the UK
Jan 11, 2021: New bioinformatics solution powers multi-omics discovery at massive scale
Dec 08, 2020: Illumina and Harvard Pilgrim Health Care expand access to whole-genome sequencing for genetic disease testing
Dec 03, 2020: Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina Collaborate on Scalable Clinical Whole-Genome Sequencing Initiative
Dec 03, 2020: NYGC collaborates on clinical whole-genome sequencing initiative to expand patient access to advanced genomic technologies

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Illumina Inc, Key Facts
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Major Products and Services
Illumina Inc, History
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Illumina Inc, Key Competitors
Illumina Inc, Ratios based on current share price
Illumina Inc, Annual Ratios
Illumina Inc, Annual Ratios (Cont...1)
Illumina Inc, Annual Ratios (Cont...2)
Illumina Inc, Interim Ratios
Illumina Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Illumina Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Illumina Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Illumina Inc, Performance Chart (2016 - 2020)
Illumina Inc, Ratio Charts
Illumina Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Illumina Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications